Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 12.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007

Recipients with Lung Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 207 100.0% 5,792 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 14 6.8% 302 5.2%
OKT3     56 1.0%
Thymoglobulin 9 4.3% 204 3.5%
Zenapax 30 14.5% 873 15.1%
Simulect 54 26.1% 1,272 22.0%
Campath 19 9.2% 313 5.4%
Rituximab     4 0.1%
No Induction Drug Reported 83 40.1% 2,808 48.5%


Source: OPTN/SRTR Data as of May 1, 2008.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader